🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase II, open-label, multicenter, randomized umbrella study to e...
Status
Recruiting
Location
Fudan University Shanghai Zhongshan Hospital
Start Date
2019-10-18
Trial ID
NCT03983226
This study is to evaluate the efficacy and safety of radiotherapy combined ...
Status
Completed
Location
Cancer Hospital and Institute, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC)
Start Date
2010-06
Trial ID
NCT02276248
Treatments Being Tested
Biliary tract cancer is a rare malignant neoplasm including intrahepatic ch...
Status
Recruiting
Location
Severance Hospital, Yonsei University Health System
Start Date
2023-05-12
Trial ID
NCT05749900
Treatments Being Tested
To decide maximum tolerated dose and recommended dose of treatment using ge...
Status
Completed
Location
Kobe University Graduate School of Medicine
Start Date
2011-01
Trial ID
NCT01297998
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as cisplatin, gemcitabine, and ...
Status
Terminated
Location
Hollings Cancer Center at Medical University of South Carolina
Start Date
2005-09-21
Trial ID
NCT00268450
Treatments Being Tested
This is a randomized, controlled, open-label, multicenter phase 3 clinical ...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2024-08-22
Trial ID
NCT06592326
Treatments Being Tested
Lung cancer is the leading cause of cancer deaths worldwide. It is estimate...
Status
Unknown
Location
fERNANDO bARATA
Start Date
2007-03
Trial ID
NCT00561054
Treatments Being Tested
The purpose of this study is to compare the efficacy between gemcitabine/ci...
Status
Terminated
Location
Gyeongsang University Hospital
Start Date
2010-07
Trial ID
NCT01096745
Treatments Being Tested
* The study is evaluating the safety and tolerability of Nivolumab (BMS-936...
Status
Completed
Location
Ucla
Start Date
2011-12-16
Trial ID
NCT01454102
Treatments Being Tested
This study was designed to compare the efficacy and safety of tislelizumab ...
Status
Completed
Location
Anhui Provincial Hospital
Start Date
2019-03-27
Trial ID
NCT03924986
Treatments Being Tested